Inhibiting dihydrodipicolinate synthase across species: towards specificity for pathogens?

Autor: Mitsakos V; School of Chemistry, University of Melbourne, Vic. 3010, Australia., Dobson RC, Pearce FG, Devenish SR, Evans GL, Burgess BR, Perugini MA, Gerrard JA, Hutton CA
Jazyk: angličtina
Zdroj: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2008 Jan 15; Vol. 18 (2), pp. 842-4. Date of Electronic Publication: 2007 Nov 13.
DOI: 10.1016/j.bmcl.2007.11.026
Abstrakt: Dihydrodipicolinate synthase (DHDPS) is a key enzyme in lysine biosynthesis and an important antibiotic target. The specificity of a range of heterocyclic product analogues against DHDPS from three pathogenic species, Bacillus anthracis, Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus, and the evolutionarily related N-acetylneuraminate lyase, has been determined. The results suggest that the development of species-specific inhibitors of DHDPS as potential antibacterials is achievable.
Databáze: MEDLINE